For example, in vivo studies have shown that transduction of tumor cells with ectopic HLA class II or CIITA increases CD4 + T cell and CD8 + T cell-mediated tumor rejection [78–81], implying that suppressing HLA class II expression is necessary for tumor progression. This evidence concerns the gene CD4 and neoplasm.